Delivery Order SPE2DB25D3110-SPE2DB25FTEBX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,371.82 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units). This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) valued at $28,718.73. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by August 4, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,370.84 to AmerisourceBergen Drug Corp for Carvedilol ER 80 mg capsules (30-count) on August 15, 2025, with completion scheduled for August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) on July 31, 2025, with a firm fixed price ceiling value of $9,931.33 and an ultimate completion date of August 1, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a $999.99 billion pharmaceutical prime vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count) valued at $2,191.03 under a firm fixed price contract. The award was executed on August 4, 2025, with an ultimate completion date of August 5, 2025, and the product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, non-set-aside procurement executed through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,944.80 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count) on August 15, 2025, with a completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $1,011.63. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $4,048.75. This delivery order represents a firm fixed price contract with no set-aside designation, indicating it was awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Carvedilol ER 10 mg capsules in quantities of 30 units. This contract is a firm fixed-price delivery order with a ceiling value of $8,619.00 and an ultimate completion date of August 8, 2025. The award was made through open competition with no set-aside designation, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of Carvedilol ER 20 mg capsules. The contract has a ceiling value of $36,516.97 and a performance period through April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC)...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEBXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count packaging) with a ceiling value of $1,010.54 under a firm fixed price contract. This award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-set-aside competitive award to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceuticals and medical supplies to support military and veteran healthcare systems worldwide. The Carvedilol ER delivery exemplifies the company's role in fulfilling routine pharmaceutical needs for Defense Health Agency operations and other government healthcare systems through the flexible and competitive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/12/25 |